Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more
Head-to-head evidence comparison — which supplement is right for you?
Huperzine A wins 2 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Likely helps
5 of 6 studies with measurable effects showed benefit.
Top outcomes
Verdict
Probably helps
4 of 7 studies with measurable effects showed benefit.
Top outcomes
Shared outcomes (1)
Outcomes where both Huperzine A and Kava have evidence — compare verdict strength side-by-side.
50-200mcg twice daily
Morning and early afternoon, Avoid evening (may cause vivid dreams)
Huperzine A capsules (standardized extract)
150-300mg kavalactones daily
Evening for relaxation, 30-60 minutes before stressful events, Before bed for sleep
Water-extracted root powder or capsules
2-4 weeks
30-60 minutes
2-4 weeks
During use
30-60 minutes
30-60 minutes
30-60 minutes
1-2 hours
The treatment of cognitive dysfunction in dementia: a multiple treatments meta-analysis
Psychopharmacology (2018) · Meta analysis · n=44854
The pooled standardized mean difference of the treatment effects on cognitive dysfunction was 0.439 (95% confidence interval 0.374, 0.504).
Traditional Chinese herbal medicine for vascular dementia
The Cochrane database of systematic reviews (2018) · Systematic review · n=3581
Two TCHMs (NaoMaiTai and TongXinLuo) had a 5% or more increased risk of AEs compared to the 'no Treatment' control, but the quality of this evidence was poor.
Interventions to delay functional decline in people with dementia: a systematic review of systematic reviews
BMJ open (2016) · Systematic review · n=289
The quality of the reviews varied; however most (65%) scored 8/11 or more on the AMSTAR tool, indicating high quality.
Herbal medicines in the treatment of psychiatric disorders: 10-year updated review
Phytotherapy research : PTR (2018) · Systematic review
Other encouraging herbal medicines with preliminary evidence include Curcuma longa (turmeric) in depression, Withania somnifera (ashwagandha) in affective disorders, and Ginkgo biloba (ginkgo) as an adjunctive treatment in Schizophrenia.
GABA-modulating phytomedicines for anxiety: A systematic review of preclinical and clinical evidence
Phytotherapy research : PTR (2018) · Systematic review
An open-ended search to 5 July 2017 was conducted using MEDLINE (PubMed), Scopus, and Cochrane library online databases and performed in a stepped format from preclinical to clinical investigations.
Herbal medicine for insomnia: A systematic review and meta-analysis
Sleep medicine reviews (2015) · Meta analysis · n=1602
There was no statistically significant difference between any herbal medicine and placebo, or any herbal medicine and active control, for any of the thirteen measures of clinical efficacy.
Based on meta-analysis showing MMSE improvement (WMD: 2.27) in dementia populations. Evidence primarily from dementia patients, limited data in healthy individuals. Quality concerns noted in systematic reviews regarding study methodology.
Based on multiple meta-analyses showing efficacy vs placebo with effect size comparable to benzodiazepines for mild-moderate anxiety. WS1490 extract showed OR=3.3 vs placebo. Effectiveness limited to 60% due to mixed results in some GAD populations and study quality limitations.
AI-estimated from published studies. Interpret as directional guidance.
Huperzine A has a higher evidence score (7.5/10 vs 9/10) and wins in 2 of 3 categories.
No known interactions between Huperzine A and Kava have been documented in our database. However, always consult a healthcare provider before combining supplements.